Skip to main content
. 2018 Aug 12;2018(3):31. doi: 10.21542/gcsp.2018.31

Table 3. Clinical, echocardiographic, and demographic features in 224 children and adolescents with HCM who underwent ICD implantation for primary or secondary prevention.

Primary Prevention Secondary Prevention
Characteristic All Study Patients Overall ≥1 Appropriate Intervention Overall ≥1 Appropriate Intervention
Number of patients 224 188 26 36§ 17
Age at implantation (yrs) 14.5 ± 3.6 14.7 ± 3.5* 14.0 ± 2.7 12.9 ± 4.4 12.9 ± 4.5
Age at first ICD intervention (yrs) 16.4 ± 4.8 17.0 ± 3.4 15.6 ± 6.4
Male 151 (67%) 124 (66%) 16 (62%) 27 (75%) 12 (71%)
Follow-Up duration (yrs) 4.3 ± 3.3 4.5 ± 3.3* 3.0 ± 2.7 3.5 ± 3.4 2.7 ± 2.7
NYHA class at implantation
I 159 (71%) 126 (67%) 20 (77%) 33 (92%) 16 (94%)
II 49 (22%) 46 (24%)* 3 (12%) 3 (8%) 1 (6%)
III/IV 16 (7%) 16 (9%)* 3 (12%) 0 0
NYHA class at last evaluation
I 159 (71%) 133 (71%) 18 (69%) 26 (72%) 9 (53%)
II 47 (21%) 39 (21%) 6 (23%) 8 (19%) 6 (35%)
III/IV 18 (8%) 16 (9%) 2 (8%) 2 (6%) 2 (12%)
Maximal LV wall thickness (mm) 25.5 ± 9.8 26.0 ± 9.3 29.8 ± 11.4 22.7 ± 11.8 21.5 ± 9.4
LV end-diastolic dimension (mm) 40.2 ± 8.8 40.5 ± 8.6 41.8 ± 15.2 38.7 ± 9.7 39.5 ± 10.5
Left atrial dimension (mm) 37.8 ± 9.2 37.9 ± 9.1 37.5±9.8 37.6 ± 9.8 34.5 ± 9.8
LV outflow gradient at rest
>30 mm Hg 54 (24%) 48 (26%) 10 (38%) 6 (17%) 3 (18%)
<30 mm Hg 170 (76%) 140 (74%) 16 (62%) 30 (83%) 14 (82%)
Cardioactive medications at implantation 158 (71%) 135 (72%) 21 (81%) 23 (64%) 11 (65%)
Cardioactive medications at first appropriate intervention 36 (84%) 21 (81%) 15 (88%)
Ejection fraction <50% 9 (4%) 5 (3%) 1 (4%) 4 (11%) 3 (8%)

Notes.

Values are mean ± SD or n (%).

*

Significant difference versus secondary prevention (p < 0.01).

Variables unassociated with the likelihood of a primary prevention ICD appropriate intervention (p = 0.054 to 0.83).

Significant difference versus secondary prevention appropriate interventions (p = 0.017).

§

Includes 10 patients with extreme LV hypertrophy with wall thickness ≥30 mm, of whom 4 had appropriate ICD shocks.

HCM
hypertrophic cardiomyopathy
ICD
implantable cardioverter-defibrillator
LV
left ventricular
NYHA
New York Heart Association